Literature DB >> 4039036

An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura.

R Hoffman, S Zaknoen, H H Yang, E Bruno, A F LoBuglio, J B Arrowsmith, J T Prchal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4039036     DOI： 10.1056/NEJM198505023121807

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Authors:  Muna Iraqi; Jose Perdomo; Feng Yan; Philip Y-I Choi; Beng H Chong
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

2.  Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists.

Authors:  Oliver Meyer; Eric Herzig; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2011-12-23       Impact factor: 3.747

3.  Expansion of Human Megakaryocyte-Lineage Progeny via Aryl Hydrocarbon Receptor Antagonism with CH223191.

Authors:  Dongchan Kim; Dong-Yeop Shin; Jun Liu; Na-Rae Jeong; Youngil Koh; Junshik Hong; Xinxin Huang; Hal E Broxmeyer; Sung-Soo Yoon
Journal:  Stem Cell Rev Rep       Date:  2022-06-10       Impact factor: 5.739

Review 4.  Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.

Authors:  Roberto Stasi; Maria L Evangelista; Sergio Amadori
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Antigenic differences between human platelets and megakaryocytes.

Authors:  P Hyde; D Zucker-Franklin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

6.  Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.

Authors:  Gregory Cheng
Journal:  Ther Adv Hematol       Date:  2012-06

7.  Human megakaryocytic progenitor cells.

Authors:  L Kanz; G W Löhr; A A Fauser
Journal:  Klin Wochenschr       Date:  1987-04-01

8.  Treatment of immune thrombocytopenic purpura: focus on eltrombopag.

Authors:  Lawrence Rice
Journal:  Biologics       Date:  2009-07-13

Review 9.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162

Review 10.  Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.

Authors:  Jose Perdomo
Journal:  Immunotargets Ther       Date:  2016-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.